{"resourceType": "Citation", "contained": [{"resourceType": "ArtifactAssessment", "id": "keywords0", "artifactReference": {"reference": "#", "type": "Citation"}, "content": [{"classifier": [{"text": "Androgen deprivation therapy"}]}, {"classifier": [{"text": "Docetaxel"}]}, {"classifier": [{"text": "Prostate cancer"}]}, {"classifier": [{"text": "Prostatic biopsy"}]}]}, {"resourceType": "Practitioner", "id": "author0", "name": [{"family": "Rajan", "given": ["Prabhakar"]}]}, {"resourceType": "Practitioner", "id": "author1", "name": [{"family": "Frew", "given": ["John A"]}]}, {"resourceType": "Practitioner", "id": "author2", "name": [{"family": "Wilson", "given": ["James M"]}]}, {"resourceType": "Practitioner", "id": "author3", "name": [{"family": "Azzabi", "given": ["Ashraf S T"]}]}, {"resourceType": "Practitioner", "id": "author4", "name": [{"family": "McMenemin", "given": ["Rhona M"]}]}, {"resourceType": "Practitioner", "id": "author5", "name": [{"family": "Stockley", "given": ["Jacqueline"]}]}, {"resourceType": "Practitioner", "id": "author6", "name": [{"family": "Soomro", "given": ["Naeem A"]}]}, {"resourceType": "Practitioner", "id": "author7", "name": [{"family": "Durkan", "given": ["Garrett"]}]}, {"resourceType": "Practitioner", "id": "author8", "name": [{"family": "Pedley", "given": ["Ian D"]}]}, {"resourceType": "Practitioner", "id": "author9", "name": [{"family": "Leung", "given": ["Hing Y"]}]}, {"resourceType": "ArtifactAssessment", "id": "meshHeading0", "artifactReference": {"reference": "#", "type": "Citation"}, "content": [{"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D000368", "display": "Aged", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D000726", "display": "Androgen Antagonists", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "Q000008", "display": "administration & dosage"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "N"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "Q000627", "display": "therapeutic use"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "Y"}]}]}]}]}, {"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D001706", "display": "Biopsy", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D000077143", "display": "Docetaxel", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D005240", "display": "Feasibility Studies", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D006801", "display": "Humans", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D008297", "display": "Male", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D008875", "display": "Middle Aged", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D011471", "display": "Prostatic Neoplasms", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "Q000188", "display": "drug therapy"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "Y"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "Q000601", "display": "surgery"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "Y"}]}]}]}]}, {"informationType": "classifier", "type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D043823", "display": "Taxoids", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "Q000008", "display": "administration & dosage"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "N"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "Q000627", "display": "therapeutic use"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "Y"}]}]}]}]}]}], "useContext": [{"code": {"system": "http://hl7.org/fhir/citation-classification-type", "code": "fevir-platform-use", "display": "FEvIR Platform Use"}, "valueCodeableConcept": {"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "medline-base", "display": "Medline Base", "userSelected": false}]}}], "classification": [{"type": {"coding": [{"system": "http://hl7.org/fhir/citation-classification-type", "code": "citation-source", "display": "Citation Source"}]}, "classifier": [{"text": "MEDLINE"}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/citation-classification-type", "code": "medline-owner", "display": "MEDLINE Citation Owner"}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value", "code": "NLM", "display": "National Library of Medicine, Index Section", "userSelected": false}]}]}], "statusDate": [{"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-received", "display": "PubMed Pubstatus of Received"}]}, "period": {"end": "2015-02-20"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-revised", "display": "PubMed Pubstatus of Revised"}]}, "period": {"end": "2015-05-08"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-accepted", "display": "PubMed Pubstatus of Accepted"}]}, "period": {"end": "2015-05-11"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-entrez", "display": "PubMed Pubstatus of Entrez"}]}, "period": {"end": "2015-06-21T06:00:00.000Z"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-pubmed", "display": "PubMed Pubstatus of Pubmed"}]}, "period": {"end": "2015-06-21T06:00:00.000Z"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-medline", "display": "PubMed Pubstatus of Medline"}]}, "period": {"end": "2016-04-15T06:00:00.000Z"}}], "citedArtifact": {"identifier": [{"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26092557"}, {"system": "https://doi.org", "value": "10.1016/j.urolonc.2015.05.012"}, {"type": {"text": "pii"}, "value": "S1078-1439(15)00235-5"}], "title": [{"text": "Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non-castration-resistant prostate cancer.", "language": {"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}, "type": [{"coding": [{"system": "http://hl7.org/fhir/title-type", "code": "primary", "display": "Primary title"}]}]}], "abstract": [{"copyright": "Copyright \u00a9 2015 Elsevier Inc. All rights reserved.", "text": "<AbstractText Label=\"BACKGROUND AND OBJECTIVE\" NlmCategory=\"OBJECTIVE\">Sequential tissue biopsies taken during clinical trials of novel systemic anticancer therapies for advanced prostate cancer (PCa) may aid pharmacodynamic evaluation and biomarker discovery. We conducted a single institution phase-II open-labeled randomized study to assess the safety, tolerability, and early efficacy of docetaxel chemotherapy plus androgen deprivation therapy (ADT) vs. ADT alone for patients with advanced non-castration-resistant PCa with sequential prostatic biopsies.</AbstractText><AbstractText Label=\"PATIENTS AND METHODS\" NlmCategory=\"METHODS\">We randomized 30 patients with newly diagnosed high-grade locally advanced or metastatic (cT3-4/N0-1/M0-1) PCa to receive ADT with (n = 15) or without (n = 15) docetaxel. Transrectal ultrasound-guided prostatic biopsies were taken at randomization and ~22 weeks after treatment initiation. Primary end point: biochemical response rate. Secondary end points: time to progression and tumor profiling.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Both treatments appear to be well tolerated, and there was no difference in mean nadir prostate-specific antigen and time to prostate-specific antigen relapse between treatment arms (P&gt;0.05). No adverse effects of pre- and post-treatment prostatic biopsies were observed. The study was neither designed nor sufficiently powered to demonstrate statistically significant differences in oncological outcomes or safety profiles between the 2 treatment arms.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Despite the lack of statistical power, our study suggests that docetaxel and ADT in combination may be well tolerated with apparently similar short-term efficacy compared with ADT alone for high-grade locally advanced or metastatic non-castration-resistant PCa, Sequential prostatic biopsies may provide tissue for tumor profiling to yield mechanistic or prognostic insights relating to novel systemic anticancer therapies.</AbstractText>"}], "publicationForm": [{"publishedIn": {"type": {"coding": [{"system": "http://hl7.org/fhir/published-in-type", "code": "D020492", "display": "Periodical"}]}, "identifier": [{"type": {"coding": [{"system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn", "code": "Electronic", "display": "Electronic"}], "text": "Electronic ISSN Type"}, "value": "1873-2496", "system": "https://portal.issn.org"}, {"type": {"text": "ISOAbbreviation"}, "system": "https://www.issn.org/services/online-services/access-to-the-ltwa/", "value": "Urol Oncol"}, {"type": {"text": "ISSN Linking"}, "system": "https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/", "value": "1078-1439"}, {"type": {"text": "Medline Title Abbreviation"}, "system": "https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html", "value": "Urol Oncol"}, {"type": {"text": "NLM Unique ID"}, "system": "https://locatorplus.gov/cgi-bin/Pwebrecon.cgi?DB=local", "value": "9805460"}], "title": "Urologic oncology", "publisherLocation": "United States"}, "citedMedium": {"coding": [{"system": "http://hl7.org/fhir/cited-medium", "code": "internet", "display": "Internet"}]}, "volume": "33", "issue": "8", "articleDate": "2015-08", "language": [{"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}], "pageString": "337.e1-6", "publicationDateText": "2015-Aug"}, {"citedMedium": {"coding": [{"system": "http://hl7.org/fhir/cited-medium", "code": "internet-without-issue", "display": "Internet without issue"}]}, "articleDate": "2015-06-16"}], "webLocation": [{"classifier": [{"coding": [{"system": "http://hl7.org/fhir/artifact-url-classifier", "code": "abstract", "display": "Abstract"}]}], "url": "https://pubmed.ncbi.nlm.nih.gov/26092557/"}, {"url": "https://doi.org/10.1016/j.urolonc.2015.05.012", "classifier": [{"coding": [{"system": "http://hl7.org/fhir/artifact-url-classifier", "code": "doi-based", "display": "DOI Based"}]}]}], "classification": [{"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "publishing-model", "display": "Publishing Model", "userSelected": false}]}, "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "Print-Electronic", "display": "Print Electronic", "userSelected": false}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "keyword", "display": "Keyword", "userSelected": false}]}, "artifactAssessment": [{"reference": "#keywords0", "type": "ArtifactAssessment", "display": "Keywords provided by NOTNLM"}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "chemical", "display": "Chemical", "userSelected": false}]}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D000726", "display": "Androgen Antagonists", "userSelected": false}]}, {"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D043823", "display": "Taxoids", "userSelected": false}]}, {"coding": [{"system": "https://www.cas.org/support/documentation/chemical-substances", "code": "15H5577CQD", "userSelected": false}, {"system": "https://meshb.nlm.nih.gov/", "code": "D000077143", "display": "Docetaxel", "userSelected": false}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH Heading"}]}, "artifactAssessment": [{"reference": "#meshHeading0", "type": "ArtifactAssessment"}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "publication-type", "display": "Publication Type"}]}, "classifier": [{"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D017427", "display": "Clinical Trial, Phase II", "userSelected": false}]}, {"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D016428", "display": "Journal Article", "userSelected": false}]}, {"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D016449", "display": "Randomized Controlled Trial", "userSelected": false}]}, {"coding": [{"system": "https://meshb.nlm.nih.gov/", "code": "D013485", "display": "Research Support, Non-U.S. Gov't", "userSelected": false}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "knowledge-artifact-type", "display": "Knowledge Artifact Type", "userSelected": false}]}, "classifier": [{"coding": [{"system": "http://hl7.org/fhir/citation-artifact-classifier", "code": "D016428", "display": "Journal Article", "userSelected": false}]}], "artifactAssessment": [{"display": "Classifier added by Computable Publishing LLC"}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "citation-subset", "display": "Citation Subset", "userSelected": false}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset", "code": "IM", "display": "IM", "userSelected": false}]}]}], "contributorship": {"entry": [{"contributor": {"reference": "#author0", "type": "Practitioner", "display": "Rajan P"}, "forenameInitials": "P", "affiliation": [{"display": "Institute of Cancer Sciences, University of Glasgow, UK. Electronic address: p.rajan@beatson.gla.ac.uk."}]}, {"contributor": {"reference": "#author1", "type": "Practitioner", "display": "Frew JA"}, "forenameInitials": "JA", "affiliation": [{"display": "Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK."}]}, {"contributor": {"reference": "#author2", "type": "Practitioner", "display": "Wilson JM"}, "forenameInitials": "JM", "affiliation": [{"display": "Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK."}]}, {"contributor": {"reference": "#author3", "type": "Practitioner", "display": "Azzabi AS"}, "forenameInitials": "AS", "affiliation": [{"display": "Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK."}]}, {"contributor": {"reference": "#author4", "type": "Practitioner", "display": "McMenemin RM"}, "forenameInitials": "RM", "affiliation": [{"display": "Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK."}]}, {"contributor": {"reference": "#author5", "type": "Practitioner", "display": "Stockley J"}, "forenameInitials": "J", "affiliation": [{"display": "Institute of Cancer Sciences, University of Glasgow, UK."}]}, {"contributor": {"reference": "#author6", "type": "Practitioner", "display": "Soomro NA"}, "forenameInitials": "NA", "affiliation": [{"display": "Newcastle Urology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK."}]}, {"contributor": {"reference": "#author7", "type": "Practitioner", "display": "Durkan G"}, "forenameInitials": "G", "affiliation": [{"display": "Newcastle Urology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK."}]}, {"contributor": {"reference": "#author8", "type": "Practitioner", "display": "Pedley ID"}, "forenameInitials": "ID", "affiliation": [{"display": "Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK."}]}, {"contributor": {"reference": "#author9", "type": "Practitioner", "display": "Leung HY"}, "forenameInitials": "HY", "affiliation": [{"display": "Institute of Cancer Sciences, University of Glasgow, UK; Cancer Research UK Beatson Institute, Bearsden, UK. Electronic address: h.leung@beatson.gla.ac.uk."}]}], "complete": true}}, "lastReviewDate": "2022-01-29", "currentState": [{"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "medline-medline", "display": "Medline Citation Status of Medline"}]}, {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-publication-status-ppublish", "display": "PubMed PublicationStatus of ppublish"}]}], "title": "26092557 Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non-castration-resistant prostate cancer.", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net", "value": "179630", "assigner": {"display": "Computable Publishing LLC"}}, {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "26092557"}], "status": "active", "meta": {"versionId": "1", "lastUpdated": "2023-11-26T22:35:30.426Z"}, "url": "https://fevir.net/resources/Citation/179630", "id": "179630", "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Computable Publishing\u00ae: MEDLINE-to-FEvIR Converter"}], "approvalDate": "2016-04-14"}